Search News
| 40.71 Delayed Data As of Aug 14 |  -0.10 / -0.25%Today’s Change | 32.32 Today|||52-Week Range 41.64 | +12.40% Year-to-Date |
| Previous close | 40.81 |
| Today’s open | 40.84 |
| Day’s range | 40.54 - 41.04 |
| Volume | 16,448,577 |
| Average volume (3 months) | 20,673,897 |
| Market cap | $239.2B |
| Earnings growth (last year) | +200.58% |
| Earnings growth (this year) | +12.85% |
| Earnings growth (next 5 years) | +6.82% |
| Revenue growth (last year) | -0.53% |
| P/E ratio | 10.9 |
| Price/Sales | 4.18 |
| Price/Book | 3.42 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.30 | -0.36% |
| MRKMerck | -0.26 | -0.39% |
| SNYSanofi | -0.21 | -0.51% |
| ABBVAbbVie | -0.86 | -0.89% |
| Next reporting date | October 30, 2018 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $52.5B |
| Annual profit (last year) | $21.3B |
| Net profit margin | 40.55% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Ian C. Read |
Chief Operating Officer & Director Albert Bourla |
Corporate headquarters New York, New York |
